STAT

JANUARY 12, 2024

MINNEAPOLIS — It’s been almost four years since George Floyd was murdered here at 38th Street and Chicago Avenue, a South Minneapolis corner anchored by a convenience store, its red awning still achingly familiar from once-saturating news coverage. Now, the legions of teddy bears placed in Floyd’s honor are dusty, the paint on street murals has chipped away, and community-built planters are overgrown.

363

363

PharmaVoice

JANUARY 12, 2024

From regulatory concerns to leadership skills, pharma leaders at JPM shared how they’re approaching the coming year.

196

196

STAT

JANUARY 12, 2024

Though the Covid-19 pandemic brought heightened attention to nurses overall, a unique nursing role has been long overlooked and, for the public, largely misunderstood: that of the nurse manager. Like nurses in other roles, nurse managers are increasingly leaving their jobs — and it’s critically important for organizations to find ways to keep them.

Hospitals 318

Hospitals 318

Safe Biologics

JANUARY 12, 2024

ASBM Records Podcast on Inflation Reduction Act’s Medicare Drug Price Setting In December, ASBM and its member organization AI Arthritis recorded an episode of the AiArthritis 360 Voices podcast examining how the IRA’s changes to the popular and highly successful Medicare Part D prescription drug benefit will negatively impact patients in coming years.

Biosimilars 130

Biosimilars Drug Pricing 130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 12, 2024

NEW YORK — During the peak of Covid-19 lockdown restrictions, Kendra Berger delivered her second child in the hospital. The experience was traumatic for Berger, a 35-year-old former nurse who lives in Holland, New York. She pushed when she wasn’t ready and her baby got stuck in the birthing canal. In the recovery room after birth, Berger started hemorrhaging and wound up needing a blood transfusion.

Hospitals 317

Hospitals 317

ALiEM - Pharm Pearls

JANUARY 12, 2024

A 42-year old Bengali man with a history of hyperlipidemia presented to the Emergency Department with facial swelling, diffuse rash, renal insufficiency and proteinuria after receiving his COVID-19 vaccine (Moderna) booster dose. There were no adverse events with the first two doses of the vaccine except for mild transient sore throat and cough after the 2nd dose.

Vaccines 130

Vaccines 130

PharmaVoice

JANUARY 12, 2024

Following a year where the FDA approved 55 new drugs, the 2024 PDUFA calendar is set with a number of potentially buzzy approvals.

130

130

STAT

JANUARY 12, 2024

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks. The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies.

Health Insurance Companies 259

Health Insurance Companies 259

The Pharmacist

JANUARY 12, 2024

A new NHS App functionality, going live 30 January, will allow patients to generate a prescription barcode to collect their medicines from any pharmacy. This will enable patients without a nominated pharmacy to take their prescription electronically to any pharmacy for collection without the need for a paper prescription. GPs already generate most prescriptions electronically […] The post NHS App to enable barcode prescriptions later this month appeared first on The Pharmacist.

120

120

STAT

JANUARY 12, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

221

221

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

JANUARY 12, 2024

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

126

126

STAT

JANUARY 12, 2024

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do expect to promenade extensively with the official mascots, catch up on our reading, and sample different types of food here and there. We also hope to hold another listening party with Mrs.

Diabetes 216

Diabetes Drug Development 216

pharmaphorum

JANUARY 12, 2024

Explore the trends and challenges in the pharmaceutical and healthcare markets, specifically focusing on phase change and the complexities of scaling up operations. Gain insights into the evolving landscape of the industry as we look ahead to 2024.

105

105

STAT

JANUARY 12, 2024

SAN FRANCISCO — Hospital leaders spent a good chunk of their stage time at the J.P. Morgan Healthcare Conference talking up their billions in cash and investment reserves. It’s a decidedly different message than the one they convey to their communities, or to Congress when they lobby for more funding. But at the high-profile health care industry conference here, nonprofit health systems need to sell investors on their message of strength and resilience.

Hospitals 201

Hospitals 201

Pharmaceutical Commerce

JANUARY 12, 2024

An overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.

104

104

STAT

JANUARY 12, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hiya! Did you catch every last important bit of news that emerged from this year’s JPM conference? Join STAT’s Tara Bannow, Damian Garde, Matthew Herper, and Allison DeAngelis today for a  virtual debrief  on how the week went.

Drug Pricing 190

Drug Pricing Drug Development 190

World Pharma News

JANUARY 12, 2024

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced the initiation of GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002 (also known as NAN-101) for the treatment of congestive heart failure (CHF).

99

99

STAT

JANUARY 12, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

183

183

pharmaphorum

JANUARY 12, 2024

Discover how Veeva Systems is revolutionising closed loop marketing and connectivity in biopharma, from clinical to medical. Learn more about innovative solutions and insights from the Veeva Commercial Summit, featuring industry expert Chris Moore and the power of data-driven strategies.

97

97

European Pharmaceutical Review

JANUARY 12, 2024

Using an investment of €120 million, Boehringer Ingelheim is set to expand and upgrade its production site in Koropi, Greece. New technologies at the facility will support the increased manufacturing capacity, the company stated on X. The expansion will boost exports of medicines from Greece to the US market. This will be the case particularly for Jardiance ® , a treatment for type 2 diabetes, chronic heart failure and chronic kidney disease (CKD), according to Boehringer Ingelheim.

Diabetes 96

Diabetes Pharmaceutical Companies Pharmaceutical Companies 96

pharmaphorum

JANUARY 12, 2024

AI technology is revolutionising the field of clinical trials by enhancing patient identification, accelerating drug development and design, and improving monitoring processes. Discover how AI is supercharging clinical trials for better healthcare outcomes.

Drug Development 97

Drug Development 97

Pharmafile

JANUARY 12, 2024

The National Institute for Health and Care Excellence (NICE) has announced that it has expanded the guidance around which patients are eligible to access Paxlovid, this review increases the figure from 3.9 million people to 5.3 million people. The drug was already available to “people who did not need supplemental oxygen for COVID-19 and who […] The post NICE expands access to Paxlovid for 1.4 million people at risk of severe COVID-19 appeared first on Pharmafile.

95

95

pharmaphorum

JANUARY 12, 2024

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has started a review of the generic and – if approved – Lantheus could be in line for 180 days of market exclusivity as the first company to bring a copycat version of Lutathera (lutetium Lu 177 dotatate) to the US market.

93

93

Express Pharma

JANUARY 12, 2024

The current unmet needs in the female contraceptives market are similar to those that were present 10 years ago. Currently, marketed contraceptives carry the risk of irregular bleeding patterns, weight gain, changes in mood, depression, migraine or headache, nausea, and acne. Side effects are one of the main reasons why patients may decide to discontinue contraceptive use, leading to unintended pregnancies.

92

92

pharmaphorum

JANUARY 12, 2024

Researchers from the Wellcome Sanger Institute and partners have carried out a comprehensive analysis of cancer cells, identifying 370 ‘priority’ targets that could be used to develop new drug therapies.

92

92

Express Pharma

JANUARY 12, 2024

Sanjay Vyas, Executive Vice President and Managing Director, Parexel India shares his budget expectations With the country focusing on Research and Development (R&D) and healthcare with much more tenacity than earlier, expectations towards similar allocation of budget towards these areas is expected for FY24-25. Additionally, continued encouragement of Foreign Direct Investment in the healthcare sector could be sustained in the months and years to come.

Biosimilars 91

Biosimilars Vaccines 91

Pharma Times

JANUARY 12, 2024

If successful, the new test could see routine screening introduced in the NHS

Hospitals 126

Hospitals 126

Welltopia Pharmacy

JANUARY 12, 2024

Introduction to Chronic Fatigue Syndrome (CFS) Chronic fatigue syndrome (CFS) is a condition that greatly affects the quality of life

Compounding 103

Compounding 103

The Pharmacist

JANUARY 12, 2024

An ITV documentary has raised questions around whether pharmacies in England will have the capacity to deliver Pharmacy First, with 48% of pharmacy workers surveyed telling the programme they do not ‘feel confident’ that they will be able to provide new services. ITV’s Tonight programme on Thursday evening placed a stark lens on the ongoing […] The post Nearly half of staff ‘not confident’ to deliver Pharmacy First amid pressures appeared first on The Pharmacist.

91

91

pharmaphorum

JANUARY 12, 2024

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure.

97

97

The Pharmacist

JANUARY 12, 2024

The director of the Royal Pharmaceutical Society (RPS) in Scotland has warned against an expectation that newly trained pharmacist prescribers will be able to ‘start prescribing without any support’ from the moment of qualification. Instead, she suggested that mentoring and decision-making tools would help the pharmacists that will qualify as prescribers at the point of […] The post New prescribers must be given ‘confidence and support’ appeared first on The Pharmacist.

87

87

Drug Channels

JANUARY 12, 2024

Today’s guest post comes from Maria Kirsch, President, Patient Services, Krista Pinto, President, Deployment Solutions, and Mike Scott, Senior Vice President, Specialty Consulting at EVERSANA. Maria, Krista, and Mike discuss the key reasons why patients abandon drug therapy. They then describe EVERSANA’s approach for helping manufacturers and healthcare providers improve adherence and health outcomes.

80

80

Pharma Times

JANUARY 12, 2024

Researchers compared 20 years of antibiotic use on E.

132

132

pharmaphorum

JANUARY 12, 2024

The FDA says it can find no evidence of increased risk of suicidal thoughts and self-harm with GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy

88

88

European Pharmaceutical Review

JANUARY 12, 2024

A recent survey from the Pistoia Alliance revealed that AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years. 1 AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years” With this increased focus on AI/ML, EPR editor Caroline Peachey sat down with Henry Levy, President of Life Sciences at Clarivate, to discuss the status, challenges a

Drug Development 78

Drug Development Pharmaceutical Companies Pharmaceutical Companies 78